Recent Finacing
Recent Raise
Graphite Bio develops a gene-editing platform that enables high-efficiency, site-specific DNA integration and homology-directed repair for ex vivo engineering of hematopoietic stem cells to treat genetic diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Graphite Bio.
